Adiponectin and atherosclerotic disease
- PMID: 15149866
- DOI: 10.1016/j.cccn.2004.02.020
Adiponectin and atherosclerotic disease
Abstract
Adiponectin has been identified as one of the "adipocytokines" that are derived only from adipose tissue, and are abundantly present in circulating blood. Adiponectin has protective actions in the initiation and progression of atherosclerosis through anti-inflammatory and anti-atherogenic effects. Adiponectin levels are decreased in obesity, type 2 diabetes, and patients with coronary artery disease (CAD). Adiponectin levels were negatively correlated with the CRP levels in patients with CAD. Adiponectin plays a crucial role in the association between obesity, type 2 diabetes, and insulin resistance. Mechanisms explaining the relationship between adiponectin and insulin resistance suggest that adiponectin and tumor necrosis factor (TNF)-alpha inhibited each other's expression and production in adipocytes. Thiazolidinediones, which are insulin-sensitizing agents, increased the production of adiponectin through directly enhancing its gene expression. The C-terminal globular domain of adiponectin may play a central role in the protective effects against atherosclerosis. Adiponectin receptors 1 (AdipoR1) and 2 (AdipoR2) are expressed ubiquitously in most organs, especially in skeletal muscle in AdipoR1, and liver in AdipoR2. With the prospect of future basic and clinical research on the molecular structure-receptor relationship, adiponectin could become a promising target for future investigations in reducing the morbidity and mortality of atherosclerotic disease.
Copyright 2004 Elsevier B.V.
Similar articles
-
Recent advances in the relationship between obesity, inflammation, and insulin resistance.Eur Cytokine Netw. 2006 Mar;17(1):4-12. Eur Cytokine Netw. 2006. PMID: 16613757 Review.
-
[Adiponectin--adipocytokine with a broad clinical spectrum].Przegl Lek. 2004;61(2):109-14. Przegl Lek. 2004. PMID: 15230153 Review. Polish.
-
[Adiponectin and its role in the pathogenesis of obesity, diabetes mellitus and insulin resistance].Pol Merkur Lekarski. 2006 Mar;20(117):355-7. Pol Merkur Lekarski. 2006. PMID: 16780274 Review. Polish.
-
Adiponectin--a key adipokine in the metabolic syndrome.Diabetes Obes Metab. 2006 May;8(3):264-80. doi: 10.1111/j.1463-1326.2005.00510.x. Diabetes Obes Metab. 2006. PMID: 16634986 Review.
-
Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.Biochem Biophys Res Commun. 2005 Oct 28;336(3):747-53. doi: 10.1016/j.bbrc.2005.08.203. Biochem Biophys Res Commun. 2005. PMID: 16157299
Cited by
-
Adiponectin in Relation to Coronary Plaque Characteristics on Radiofrequency Intravascular Ultrasound and Cardiovascular Outcome.Arq Bras Cardiol. 2018 Sep;111(3):345-353. doi: 10.5935/abc.20180172. Arq Bras Cardiol. 2018. PMID: 30379252 Free PMC article.
-
Gender-specific risk factors for peripheral artery disease in a voluntary screening population.J Am Heart Assoc. 2014 Mar 13;3(2):e000651. doi: 10.1161/JAHA.113.000651. J Am Heart Assoc. 2014. PMID: 24627420 Free PMC article.
-
The Association Between Psoriasis and Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis of Observational Studies.Cureus. 2024 Jun 28;16(6):e63379. doi: 10.7759/cureus.63379. eCollection 2024 Jun. Cureus. 2024. PMID: 38947134 Free PMC article. Review.
-
Adiponectin blood levels and autism spectrum disorders: a systematic review.BMC Psychiatry. 2024 Jan 31;24(1):88. doi: 10.1186/s12888-024-05529-1. BMC Psychiatry. 2024. PMID: 38297246 Free PMC article.
-
Emerging biomarkers for the detection of cardiovascular diseases.Egypt Heart J. 2022 Oct 20;74(1):77. doi: 10.1186/s43044-022-00317-2. Egypt Heart J. 2022. PMID: 36264449 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
